|
CSNK1G1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.151300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.431010E-01 |
| Normal-vs-Stage2 |
1.028180E-02 |
| Normal-vs-Stage3 |
2.60590000000782E-06 |
| Normal-vs-Stage4 |
3.404400E-04 |
| Stage1-vs-Stage2 |
7.620100E-02 |
| Stage1-vs-Stage3 |
3.598199999999E-05 |
| Stage1-vs-Stage4 |
3.624600E-03 |
| Stage2-vs-Stage3 |
2.173600E-01 |
| Stage2-vs-Stage4 |
5.334200E-01 |
| Stage3-vs-Stage4 |
5.603200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.262390E-03 |
| Normal-vs-AfricanAmerican |
1.016620E-03 |
| Normal-vs-Asian |
8.772600E-01 |
| Caucasian-vs-AfricanAmerican |
2.397800E-01 |
| Caucasian-vs-Asian |
4.089400E-01 |
| AfricanAmerican-vs-Asian |
1.943220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.351600E-04 |
| Normal-vs-Female |
1.144110E-02 |
| Male-vs-Female |
3.458200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.344000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.733860E-02 |
| Normal-vs-Age(61-80Yrs) |
5.775200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.140610E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.866200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.645200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.128000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.033800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.757900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.956980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.633200E-01 |
| Normal-vs-Grade 2 |
1.386400E-01 |
| Normal-vs-Grade 3 |
2.981100E-04 |
| Normal-vs-Grade 4 |
1.54720000000719E-06 |
| Grade 1-vs-Grade 2 |
2.317600E-01 |
| Grade 1-vs-Grade 3 |
1.587620E-02 |
| Grade 1-vs-Grade 4 |
1.617290E-03 |
| Grade 2-vs-Grade 3 |
3.661000E-03 |
| Grade 2-vs-Grade 4 |
2.170100E-04 |
| Grade 3-vs-Grade 4 |
7.151500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.045200E-01 |
| Normal-vs-ccB subtype |
1.999330E-04 |
| ccA subtype-vs-ccB subtype |
1.379540E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.739000E-03 |
| Normal-vs-N1 |
3.884800E-01 |
| N0-vs-N1 |
9.149400E-01 |
|
|
